Clinical Trial Update: Baricitinib Effects on Procoagulant State in Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

A Phase 4 study is investigating the effect of baricitinib on the procoagulant state in rheumatoid arthritis, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Baricitinib (baricitinib)

Snippet

Sponsor: Tanta University | Conditions: Rheumatoid Arthritis | Phase 4 | Status: NOT_YET_RECRUITING